title: Infliximab treatment of massive upper gastrointestinal bleeding in gastroduodenal Crohn's disease.
authors.forename: Orhan
authors.initials: O
authors.lastname: Kocaman
authors.forename: Cem
authors.initials: C
authors.lastname: Aygün
authors.forename: Tolga
authors.initials: T
authors.lastname: Konduk
authors.forename: Altay
authors.initials: A
authors.lastname: Celebi
authors.forename: Omer
authors.initials: O
authors.lastname: Sentürk
authors.forename: Sadettin
authors.initials: S
authors.lastname: Hülagü
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications*; D016099:Endoscopy, Gastrointestinal; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab